Complete financial analysis of RaySearch Laboratories AB (publ) (RAY-B.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of RaySearch Laboratories AB (publ), a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Applied Development Holdings Limited (0519.HK) Income Statement Analysis – Financial Results
- Troilus Gold Corp. (CHXMF) Income Statement Analysis – Financial Results
- Canna-Global Acquisition Corp (CNGLU) Income Statement Analysis – Financial Results
- Nanfang Black Sesame Group Co., Ltd. (000716.SZ) Income Statement Analysis – Financial Results
- Toyota Motor Corporation (TYT.L) Income Statement Analysis – Financial Results
RaySearch Laboratories AB (publ) (RAY-B.ST)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.raysearchlabs.com
About RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also develops RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information system to support cancer treatment activities. In addition, it offers RayCommand, a treatment control system that is compatible with various hardware models and supports advanced functionalities of treatment machines and software systems; and RayIntelligence, a cloud-based oncology analytics system that turns patient data into insights. Further, the company provides training courses related to its products. RaySearch Laboratories AB (publ) is headquartered in Stockholm, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.02B | 843.65M | 641.67M | 651.61M | 741.58M | 627.22M | 585.09M | 531.47M | 397.60M | 285.22M | 204.47M | 182.09M | 126.10M | 117.73M | 83.69M | 62.69M | 64.71M | 68.98M | 69.86M | 39.48M | 22.15M |
| Cost of Revenue | 106.58M | 94.99M | 50.40M | 43.37M | 72.37M | 56.02M | 36.65M | 26.87M | 23.69M | 11.63M | 6.06M | 3.03M | 442.00K | 92.00K | 1.01M | 661.00K | 863.00K | 849.00K | 1.12M | 1.24M | 1.75M |
| Gross Profit | 915.58M | 748.66M | 591.28M | 608.24M | 669.22M | 571.20M | 548.44M | 504.60M | 373.91M | 273.59M | 198.41M | 179.06M | 125.66M | 117.64M | 82.67M | 62.03M | 63.84M | 68.13M | 68.73M | 38.24M | 20.39M |
| Gross Profit Ratio | 89.57% | 88.74% | 92.15% | 93.34% | 90.24% | 91.07% | 93.74% | 94.94% | 94.04% | 95.92% | 97.04% | 98.34% | 99.65% | 99.92% | 98.79% | 98.95% | 98.67% | 98.77% | 98.40% | 96.86% | 92.08% |
| Research & Development | 237.74M | 238.77M | 233.44M | 185.04M | 174.67M | 147.69M | 104.30M | 93.21M | 101.51M | 95.07M | 90.72M | 78.66M | 57.58M | 53.50M | 24.72M | 29.18M | 24.23M | 11.56M | 11.05M | 10.80M | 3.30M |
| General & Administrative | 195.16M | 171.72M | 122.04M | 106.29M | 100.14M | 91.98M | 63.25M | 66.29M | 43.24M | 30.74M | 80.11M | 39.28M | 21.37M | 17.76M | 12.69M | 11.03M | 12.53M | 11.57M | 11.17M | 11.00M | 8.92M |
| Selling & Marketing | 362.85M | 309.42M | 300.19M | 291.23M | 345.43M | 261.91M | 204.85M | 156.84M | 138.36M | 78.43M | 53.02M | 36.27M | 19.22M | 4.69M | 3.60M | 2.56M | 1.37M | 2.17M | 1.42M | 1.14M | 918.00K |
| SG&A | 558.01M | 481.14M | 422.23M | 397.52M | 445.56M | 353.89M | 268.10M | 223.13M | 181.60M | 109.17M | 133.13M | 75.55M | 40.58M | 22.44M | 16.30M | 13.59M | 13.89M | 13.74M | 12.58M | 12.13M | 9.83M |
| Other Expenses | 4.96M | -1.56M | -353.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -122.00K | 1.82M | 799.00K | -1.81M | -55.00K | 5.87M | 8.89M | 500.00K | -948.00K |
| Operating Expenses | 800.70M | 718.35M | 655.32M | 582.56M | 620.23M | 501.59M | 372.40M | 316.34M | 283.11M | 204.24M | 223.85M | 154.20M | 98.04M | 77.76M | 41.81M | 40.97M | 38.06M | 31.17M | 32.52M | 23.44M | 12.19M |
| Cost & Expenses | 907.28M | 813.34M | 705.72M | 625.93M | 692.60M | 557.61M | 409.05M | 343.21M | 306.80M | 215.87M | 229.91M | 157.23M | 98.48M | 77.86M | 42.83M | 41.63M | 38.92M | 32.02M | 33.64M | 24.68M | 13.94M |
| Interest Income | 4.90M | 1.11M | 708.00K | 2.74M | 1.26M | 283.00K | 368.00K | 19.00K | 260.00K | 314.00K | 852.00K | 412.00K | 1.11M | 252.00K | 425.00K | 3.10M | 2.57M | 1.34M | 474.00K | 238.00K | 799.00K |
| Interest Expense | 9.69M | 11.48M | 6.04M | 5.70M | 6.74M | 2.28M | 2.16M | 1.51M | 2.13M | 973.00K | 97.00K | 36.00K | 29.00K | 3.00K | 4.00K | 49.00K | 310.00K | 19.00K | -1.07M | 80.00K | 48.00K |
| Depreciation & Amortization | 286.15M | 296.99M | 250.00M | 76.55M | 68.88M | 18.23M | 70.79M | 67.34M | 50.00M | 54.00M | 53.00M | 48.50M | 1.11M | 252.00K | 425.00K | 3.10M | 2.57M | 5.98M | 5.21M | 238.00K | 12.10M |
| EBITDA | 405.94M | 340.85M | 197.36M | 75.82M | 138.31M | 112.97M | 230.83M | 266.93M | 145.62M | 133.67M | 28.13M | 68.60M | 62.97M | 40.13M | 41.29M | 24.16M | 28.35M | 40.85M | 45.29M | 15.04M | 9.00M |
| EBITDA Ratio | 39.71% | 40.40% | 30.76% | 32.72% | 34.03% | 33.01% | 38.98% | 50.16% | 36.62% | 46.87% | 13.76% | 39.60% | 22.78% | 34.08% | 49.34% | 38.53% | 43.82% | 59.20% | 64.74% | 38.10% | 40.66% |
| Operating Income | 114.88M | 42.74M | -52.64M | -782.00K | 68.17M | 69.61M | 159.67M | 199.56M | 95.34M | 79.36M | -25.72M | 22.55M | 27.62M | 39.87M | 40.86M | 21.06M | 25.78M | 33.54M | 39.61M | 14.80M | -3.10M |
| Operating Income Ratio | 11.24% | 5.07% | -8.20% | -0.12% | 9.19% | 11.10% | 27.29% | 37.55% | 23.98% | 27.82% | -12.58% | 12.38% | 21.91% | 33.87% | 48.83% | 33.59% | 39.84% | 48.63% | 56.70% | 37.50% | -13.99% |
| Total Other Income/Expenses | -4.79M | -10.37M | -5.33M | -3.01M | -5.56M | -3.70M | -3.77M | -1.47M | -1.85M | -659.00K | 754.00K | 1.02M | 1.08M | 249.00K | 421.00K | 3.05M | 2.26M | 1.32M | 408.00K | 158.00K | 751.00K |
| Income Before Tax | 110.09M | 32.38M | -58.67M | -6.48M | 62.61M | 90.76M | 155.90M | 198.09M | 93.49M | 78.70M | -24.97M | 23.56M | 28.70M | 40.12M | 41.28M | 24.11M | 28.04M | 34.86M | 40.02M | 14.96M | -2.35M |
| Income Before Tax Ratio | 10.77% | 3.84% | -9.14% | -0.99% | 8.44% | 14.47% | 26.65% | 37.27% | 23.51% | 27.59% | -12.21% | 12.94% | 22.76% | 34.08% | 49.33% | 38.45% | 43.34% | 50.54% | 57.28% | 37.90% | -10.60% |
| Income Tax Expense | 28.52M | 8.60M | -11.36M | 2.60M | 12.20M | 12.24M | 38.27M | 46.68M | 23.28M | 18.87M | -4.13M | 3.70M | 11.70M | 11.23M | 11.14M | 5.88M | 8.26M | -1.36M | 10.87M | 2.06M | 2.68M |
| Net Income | 81.57M | 23.78M | -47.32M | -9.08M | 50.41M | 78.52M | 117.63M | 151.41M | 70.21M | 59.83M | -20.84M | 19.86M | 17.01M | 28.90M | 30.15M | 18.22M | 19.78M | 36.22M | 29.14M | 12.90M | -5.02M |
| Net Income Ratio | 7.98% | 2.82% | -7.37% | -1.39% | 6.80% | 12.52% | 20.10% | 28.49% | 17.66% | 20.98% | -10.19% | 10.91% | 13.49% | 24.54% | 36.02% | 29.07% | 30.57% | 52.51% | 41.72% | 32.68% | -22.68% |
| EPS | 2.38 | 0.69 | -1.38 | -0.26 | 1.47 | 2.29 | 3.43 | 4.42 | 2.05 | 1.75 | -0.61 | 0.58 | 0.50 | 0.84 | 0.88 | 0.53 | 0.58 | 1.06 | 0.85 | 0.41 | -0.34 |
| EPS Diluted | 2.38 | 0.69 | -1.38 | -0.26 | 1.47 | 2.29 | 3.43 | 4.42 | 2.05 | 1.75 | -0.61 | 0.58 | 0.50 | 0.84 | 0.88 | 0.53 | 0.57 | 1.05 | 0.85 | 0.38 | -0.31 |
| Weighted Avg Shares Out | 34.28M | 34.28M | 34.28M | 34.28M | 34.28M | 34.28M | 34.28M | 34.28M | 34.28M | 34.28M | 34.05M | 33.98M | 34.28M | 34.28M | 34.28M | 34.28M | 34.28M | 34.28M | 34.09M | 31.54M | 14.76M |
| Weighted Avg Shares Out (Dil) | 34.28M | 34.28M | 34.28M | 34.28M | 34.28M | 34.28M | 34.28M | 34.28M | 34.28M | 34.28M | 34.05M | 33.98M | 34.28M | 34.28M | 34.28M | 34.28M | 34.49M | 34.45M | 34.18M | 34.28M | 15.98M |
Source: https://incomestatements.info
Category: Stock Reports